Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response

DSpace/Manakin Repository

Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response

Citable link to this page

. . . . . .

Title: Photodynamic Therapy of Tumors Can Lead to Development of Systemic Antigen-Specific Immune Response
Author: Szokalska, Angelika; Mroz, Pawel A.; Wu, Mei X.; Hamblin, Michael

Note: Order does not necessarily reflect citation order of authors.

Citation: Mroz, Pawel, Angelika Szokalska, Mei X. Wu, and Michael R. Hamblin. 2010. Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. PLoS ONE 5(12): e15194.
Full Text & Related Files:
Abstract: Background: The mechanism by which the immune system can effectively recognize and destroy tumors is dependent on recognition of tumor antigens. The molecular identity of a number of these antigens has recently been identified and several immunotherapies have explored them as targets. Photodynamic therapy (PDT) is an anti-cancer modality that uses a non-toxic photosensitizer and visible light to produce cytotoxic reactive oxygen species that destroy tumors. PDT has been shown to lead to local destruction of tumors as well as to induction of anti-tumor immune response. Methodology/Principal Findings: We used a pair of equally lethal BALB/c colon adenocarcinomas, CT26 wild-type (CT26WT) and CT26.CL25 that expressed a tumor antigen, β-galactosidase (β-gal), and we treated them with vascular PDT. All mice bearing antigen-positive, but not antigen-negative tumors were cured and resistant to rechallenge. T lymphocytes isolated from cured mice were able to specifically lyse antigen positive cells and recognize the epitope derived from beta-galactosidase antigen. PDT was capable of destroying distant, untreated, established, antigen-expressing tumors in 70% of the mice. The remaining 30% escaped destruction due to loss of expression of tumor antigen. The PDT anti-tumor effects were completely abrogated in the absence of the adaptive immune response. Conclusion: Understanding the role of antigen-expression in PDT immune response may allow application of PDT in metastatic as well as localized disease. To the best of our knowledge, this is the first time that PDT has been shown to lead to systemic, antigen- specific anti-tumor immunity.
Published Version: doi:10.1371/journal.pone.0015194
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001867/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4739297

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters